Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

[1]  R. Barrett,et al.  Economic, racial and ethnic disparities in breast cancer in the US: towards a more comprehensive model. , 2009, Health & place.

[2]  L. Hemkens,et al.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study , 2009, Diabetologia.

[3]  T. Thiede,et al.  Bladder tumours induced by chlornaphazine. A five-year follow-up study of chlornaphazine-treated patients with polycythaemia. , 2009, Acta medica Scandinavica.

[4]  L. Holmberg,et al.  The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.

[5]  H. Werner,et al.  Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cells , 2009, Diabetes/metabolism research and reviews.

[6]  D. Mayer,et al.  Proliferative effects of insulin analogues on mammary epithelial cells , 2008, Archives of physiology and biochemistry.

[7]  Anders Sundström,et al.  The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.

[8]  J. Adolfsson,et al.  A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods , 2006, Acta oncologica.

[9]  J. Klenk,et al.  Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria , 2005, British Journal of Cancer.

[10]  A. Evans,et al.  Serum Insulin-Like Growth Factor-I Levels and Prostatic Intraepithelial Neoplasia: A Clue to the Relationship Between IGF-I Physiology and Prostate Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  Dario R Alessi,et al.  Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.

[12]  F. Couch.  Genetic Epidemiology of BRCA1 , 2004, Cancer biology & therapy.

[13]  Björn Eliasson,et al.  The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. , 2003, Diabetes care.

[14]  T. Hartge,et al.  Textbook of Cancer Epidemiology , 2003 .

[15]  M. Rosén.  National Health Data Registers: a Nordic heritage to public health , 2002, Scandinavian journal of public health.

[16]  K J Rothman,et al.  Exploring the relation of alcohol consumption to risk of breast cancer. , 2001, American journal of epidemiology.

[17]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[18]  W. Willett,et al.  A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  G. Steineck,et al.  Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[20]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[21]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[22]  C. la Vecchia,et al.  Alcohol and breast cancer in the Swiss Canton of Vaud. , 1996, European journal of cancer.

[23]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[24]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[25]  D. Easton,et al.  The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium. , 1994, Lancet.

[26]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[27]  C. Lowe,et al.  Age at any birth and breast cancer risk , 1983, International journal of cancer.

[28]  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. , 1997, Lancet.

[29]  B. Källén,et al.  Delivery outcome of women working in laboratories during pregnancy. , 1984, Archives of environmental health.

[30]  B Mattsson,et al.  Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. , 1984, Acta radiologica. Oncology.

[31]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.